Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualization and Optical Manipulation of the Erectile Tissue, Penile Corpus Cavernous.

Biological & pharmaceutical bulletin·2025
Same author

Correction: Editorial: Mechanisms of microenvironment governed plasticity and progression in solid tumors.

Frontiers in cell and developmental biology·2025
Same author

Genetic knockout suggests Isl1 enhancer redundancy in mouse hindlimb development.

Developmental biology·2025
Same author

Zebrafish sall1a and sall4 contribute to body elongation.

Developmental biology·2025
Same author

Topohistological alignments of ocular/penile organs.

Anatomical science international·2025
Same author

METTL14 regulates chondrogenesis through the GDF5-RUNX-extracellular matrix gene axis during limb development.

Nature communications·2025

Related Experiment Video

Updated: May 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Designer TGFβ superfamily ligands with diversified functionality.

George P Allendorph1, Jessica D Read, Yasuhiko Kawakami

  • 1Joint Center for Biosciences at Lee Gil Ya Cancer and Diabetes Institute, Gachon University for Medicine and Science, Incheon, Korea.

Plos One
|November 11, 2011
PubMed
Summary
This summary is machine-generated.

We engineered novel Transforming Growth Factor-beta (TGFβ) superfamily ligands using the RASCH strategy. These chimeric proteins offer unique signaling properties and improved therapeutic potential for various biological applications.

More Related Videos

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
06:57

Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos

Published on: July 21, 2021

Related Experiment Videos

Last Updated: May 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
06:57

Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos

Published on: July 21, 2021

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Engineering

Background:

  • Transforming Growth Factor-beta (TGFβ) superfamily ligands are crucial in development and cellular processes.
  • These ligands, including Activins, GDFs, and BMPs, are promising targets for protein-based therapeutics.

Purpose of the Study:

  • To develop a strategy (RASCH) for engineering chemically-refoldable TGFβ superfamily ligands with novel signaling properties.
  • To create and characterize new chimeric TGFβ ligands for expanded biological and clinical applications.

Main Methods:

  • Development of the RASCH (Random Assembly of Segmental Chimera and Heteromer) strategy.
  • Engineering of chimeric ligands (e.g., AB208 from Activin-βA and BMP-2).
  • Assessment of refolding characteristics and signaling pathways (e.g., Smad1) of engineered ligands.

Main Results:

  • The engineered ligand AB208 demonstrated BMP-2 refolding with Activin-like signaling.
  • New ligands (AB204, AB211, AB215) showed enhanced Smad1 pathway activation and Noggin insensitivity.
  • Incorporation of a BMP-2 N-terminal segment enabled refolding of BMP-9.

Conclusions:

  • The RASCH strategy successfully generates chemically-refoldable chimeric TGFβ ligands.
  • Engineered ligands possess unique signaling profiles, expanding the functional repertoire of TGFβ superfamily proteins.
  • These novel ligands hold potential for diverse biological and clinical applications.